| Alcohol abstinence improves prognosis across all stages of portal hypertension in alcohol-related cirrhosis BS Hofer, B Simbrunner, L Hartl, M Jachs, DJM Bauer, L Balcar, ... Clinical Gastroenterology and Hepatology 21 (9), 2308-2317. e7, 2023 | 55 | 2023 |
| Carvedilol achieves higher hemodynamic response and lower rebleeding rates than propranolol in secondary prophylaxis M Jachs, L Hartl, B Simbrunner, D Bauer, R Paternostro, L Balcar, B Hofer, ... Clinical Gastroenterology and Hepatology 21 (9), 2318-2326. e7, 2023 | 48 | 2023 |
| Dynamics in liver stiffness measurements predict outcomes in advanced chronic liver disease G Semmler, Z Yang, L Fritz, F Köck, BS Hofer, L Balcar, L Hartl, M Jachs, ... Gastroenterology 165 (4), 1041-1052, 2023 | 42 | 2023 |
| Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event L Balcar, M Tonon, G Semmler, V Calvino, L Hartl, S Incicco, M Jachs, ... JHEP Reports 4 (8), 100513, 2022 | 39 | 2022 |
| Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertension R Paternostro, C Bardach, BS Hofer, B Scheiner, P Schwabl, ... Liver International 41 (4), 799-809, 2021 | 38 | 2021 |
| Nuclear receptors in liver fibrosis P Königshofer, K Brusilovskaya, O Petrenko, BS Hofer, P Schwabl, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1867 (12), 166235, 2021 | 33 | 2021 |
| The Baveno VII concept of cirrhosis recompensation T Reiberger, BS Hofer Digestive and Liver Disease 55 (4), 431-441, 2023 | 31 | 2023 |
| Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies P Königshofer, BS Hofer, K Brusilovskaya, B Simbrunner, O Petrenko, ... Hepatology 75 (3), 610-622, 2022 | 31 | 2022 |
| The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices R Paternostro, J Becker, BS Hofer, V Panagl, H Schiffke, B Simbrunner, ... Digestive and Liver Disease 54 (4), 500-508, 2022 | 23 | 2022 |
| Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol‐related cirrhosis BS Hofer, B Simbrunner, L Hartl, M Jachs, L Balcar, R Paternostro, ... Liver International 43 (10), 2220-2231, 2023 | 22 | 2023 |
| COVID‐19‐related downscaling of in‐hospital liver care decreased patient satisfaction and increased liver‐related mortality L Hartl, G Semmler, BS Hofer, N Schirwani, M Jachs, B Simbrunner, ... Hepatology Communications 5 (10), 1660-1675, 2021 | 20 | 2021 |
| Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis J Reiniš, O Petrenko, B Simbrunner, BS Hofer, F Schepis, M Scoppettuolo, ... Journal of Hepatology 78 (2), 390-400, 2023 | 18 | 2023 |
| Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis B Simbrunner, L Hartl, M Jachs, DJM Bauer, B Scheiner, BS Hofer, ... JHEP Reports 5 (5), 100712, 2023 | 17 | 2023 |
| Acute hemodynamic response to propranolol predicts bleeding and nonbleeding decompensation in patients with cirrhosis BS Hofer, B Simbrunner, DJM Bauer, R Paternostro, P Schwabl, ... Hepatology Communications 6 (9), 2569-2580, 2022 | 14 | 2022 |
| Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and non-cirrhotic portal hypertension P Schwabl, BA Seeland, F Riedl, TL Schubert, P Königshofer, ... Advances in Medical Sciences 67 (1), 154-162, 2022 | 12 | 2022 |
| Baveno Cooperation: an EASL consortium L Balcar, M Tonon, G Semmler, V Calvino, L Hartl, S Incicco, M Jachs, ... Risk of further decompensation/mortality in patients with cirrhosis and …, 2022 | 9 | 2022 |
| Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient M Jachs, L Hartl, B Simbrunner, G Semmler, L Balcar, BS Hofer, ... Journal of Hepatology 80 (5), 744-752, 2024 | 8 | 2024 |
| Decreased platelet activation predicts hepatic decompensation and mortality in patients with cirrhosis BS Hofer, K Brusilovskaya, B Simbrunner, L Balcar, B Eichelberger, S Lee, ... Hepatology 80 (5), 1120-1133, 2024 | 7 | 2024 |
| Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease N Dominik, B Scheiner, A Zanetto, L Balcar, G Semmler, E Campello, ... Alimentary Pharmacology & Therapeutics 59 (11), 1376-1386, 2024 | 6 | 2024 |
| Platelet Function Decreases with Increasing Severity of Liver Cirrhosis and Portal Hypertension—A Prospective Study K Brusilovskaya, BS Hofer, B Simbrunner, B Eichelberger, S Lee, ... Thrombosis and Haemostasis 123 (12), 1140-1150, 2023 | 6 | 2023 |
